DOC generici pharmaceuticals

DOC generici is a prominent Italian pharmaceutical brand specializing in generic medications. Established in the late 1990s, the company focuses on providing high-quality, essential medicines at affordable prices across various therapeutic areas including cardiovascular, gastrointestinal, and respiratory health.

While founded and headquartered in Italy, the manufacturing of their generic drugs occurs across multiple countries, leveraging a global network of specialized pharmaceutical production facilities that adhere to international regulatory standards. This ensures a consistent supply of generic therapeutic solutions for the Italian market.

Ownership of DOC generici has transitioned through several private equity firms. Currently, it is under the stewardship of ICG (Intermediate Capital Group) and Merieux Equity Partners. This ownership structure supports the company's growth as a leader in the generic drug sector in Southern Europe, maintaining its strong Italian identity while benefiting from international investment.